France *-* Supreme Court Allows Follow*-*on Damages Action by Health Insurer in Wake of Sanofi's Denigration Strategy against Generic Rivals Briefings
European Commission Sends Statement of Objections to Teva over Abusive Patent Filings and Disparagement of Generic Competitors Briefings
French Competition Authority *-* Genentech, Novartis and Roche Fined EUR 444 million in Saga Involving Wet Age*-*Related Macular Degeneration Briefings
Court of Justice of European Union Rules that Pay*-*for*-*Delay Patent Settlements May Restrict Competition 'by Object' Briefings
European Commission Opens Investigation into Teva over Suspected Abusive Patent Filings and Disparagement of Generic Competitors Briefings
French Competition Authority Fines Johnson & Johnson EUR 25 million for Hampering Market Entry of Generic Rivals Briefings
French Supreme Court rejects appeal and upholds competition law decision against Janssen Cilag for strategies against entry of generic competitors Briefings
Alleged Anticompetitive Bundling of MS Treatment & Diagnostic *–* Italian Competition Authority Investigates Biogen Briefings
Belgian Competition Authority Investigates AutoScout24 Platform for Possible Abuse of Dominance Briefings
Hungarian Competition Authority Pursues Several Members of the Supply Chain for Over*-*the*-*Counter Medicines Briefings
VBB partner Claire Simpson and counsel Catherine Gordley speak at Informa Connect's CompLaw Nordic 2026 conference Events
Belgian Competition Authority Accuses IQVIA of Abusive Behaviour Involving Pharmaceutical Data Briefings
Belgium and the Netherlands - Trend towards Closer Competition Scrutiny of Small Transactions Intensifies Briefings
Spain and the Netherlands - Competition Authorities Begin and End Inquiries in Pharmaceutical Industry Briefings
Competition and Markets Authority Investigates Vifor over Possibly Misleading Claims regarding Rival's Product Briefings
Spain - Competition Authority Starts Investigation of Loyalty-Inducing Practices towards Pharmacies Briefings
European Commission Market Tests Commitments Offered by Vifor Regarding Messaging Involving Intravenous Iron Treatment of Rival Briefings
European Commission Imposes Fine of Nearly EUR 340 Million on Mondelēz in Decision that May Portend Further Competition Scrutiny Briefings
Italian Competition Authority Investigates Alleged Effort by Novartis, Samsung Bioepis, Others to Delay Launch of Biosimilar Version of Ranibizumab Briefings
European Commission Accepts Vifor's Commitments Regarding Messaging Involving Rival's Intravenous Iron Treatment and Closes Competition File Briefings
European Commission publishes draft Guidelines on exclusionary abuses: lowering the bar for intervention Briefings
Greek Competition Authority Targets Novartis for Alleged Exclusionary Behaviour on Market for Treatment of Macular Diseases Briefings
Swiss Competition Authority and European Commission Terminate Inquiry Into Novartis Patent Litigation Briefings
Romania - Roche Fails in Attempts to Have Findings of Abusive Behaviour in relation to Oncology Medicines Overturned Briefings
European Commission Imposes Heavy Fine on Teva for Misuse of Patent System and Disparaging Rival's Product Briefings
UK Competition Appeal Tribunal quashes CMA’s excessive pricing decision against Pfizer and Flynn, but still finds abuse Briefings
Belgian Competition Authority To Investigate Wholesale and On-Trade Commercial Conditions of AB InBev Briefings
The Netherlands - Leadiant Sees Excessive Pricing Decision Largely Confirmed By Rotterdam Court Briefings
Belgian Competition Authority Accuses Roche of Hampering Biosimilar Market Entry in Oncology Briefings
Belgian Competition Authority Again Stops Below-Threshold Merger on Basis of Antitrust Rules Rather Than Merger Control Provisions Briefings
Following European Commission UK CMA Also Concludes Procedure Against Vifor Obtaining Commitments but Not Finding Infringement Briefings
Abusive Promotional & Regulatory Activities French Supreme Court Reinstates €444 Million Fines on Novartis, Roche and Genentech Briefings
French Competition Authority Imposes Substantial Fine on Telemedicine Firm on Account of Abusive Conduct Briefings